Literature DB >> 4038766

Human renal carcinoma: characterization of five new cell lines.

H B Grossman, G Wedemeyer, L Q Ren.   

Abstract

Five human renal carcinoma cell lines have been established in long-term tissue culture. Two of the cell lines, UM-RC-2 and UM-RC-3, produced clear cell tumors in athymic nude mice. The cell lines have been characterized by staining with oil red O, doubling time in vitro, and number of chromosomes. Although protein A assay reactivity of autologous combinations of patient's sera and tumor cells were seen with all five cell lines, similar binding was also found with autologous normal kidney cultures. However, the immune adherence assay demonstrated low titer autologous reactivity with two renal carcinoma cell lines but not with the corresponding normal kidney cultures. This strongly suggest host recognition of tumor-associated antigens. Characterization of cell surface antigens with murine monoclonal antibodies demonstrated shared reactivity between normal kidney tubular cells and renal carcinoma cells. Antibody A68.11 reacted strongly with all five cell lines. Antibody A80 bound to only UM-RC-3 and UM-RC-6.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4038766     DOI: 10.1002/jso.2930280320

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  21 in total

1.  Separation of extra- and intracellular metabolites using hyperpolarized (13)C diffusion weighted MR.

Authors:  Bertram L Koelsch; Renuka Sriram; Kayvan R Keshari; Christine Leon Swisher; Mark Van Criekinge; Subramaniam Sukumar; Daniel B Vigneron; Zhen J Wang; Peder E Z Larson; John Kurhanewicz
Journal:  J Magn Reson       Date:  2016-07-09       Impact factor: 2.229

2.  Protective function of von Hippel-Lindau protein against impaired protein processing in renal carcinoma cells.

Authors:  M Gorospe; J M Egan; B Zbar; M Lerman; L Geil; I Kuzmin; N J Holbrook
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

3.  HIF-independent synthetic lethality between CDK4/6 inhibition and VHL loss across species.

Authors:  Hilary E Nicholson; Zeshan Tariq; Benjamin E Housden; Rebecca B Jennings; Laura A Stransky; Norbert Perrimon; Sabina Signoretti; William G Kaelin
Journal:  Sci Signal       Date:  2019-10-01       Impact factor: 8.192

4.  Ultrastructural appearance and cytoskeletal architecture of the clear, chromophilic, and chromophobe types of human renal cell carcinoma in vitro.

Authors:  C D Gerharz; R Moll; S Störkel; U Ramp; W Thoenes; H E Gabbert
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

Review 5.  Choosing The Right Animal Model for Renal Cancer Research.

Authors:  Paweł Sobczuk; Anna Brodziak; Mohammed Imran Khan; Stuti Chhabra; Michał Fiedorowicz; Marlena Wełniak-Kamińska; Kamil Synoradzki; Ewa Bartnik; Agnieszka Cudnoch-Jędrzejewska; Anna M Czarnecka
Journal:  Transl Oncol       Date:  2020-02-22       Impact factor: 4.243

6.  Neuronal pentraxin 2 supports clear cell renal cell carcinoma by activating the AMPA-selective glutamate receptor-4.

Authors:  Christina A von Roemeling; Derek C Radisky; Laura A Marlow; Simon J Cooper; Stefan K Grebe; Panagiotis Z Anastasiadis; Han W Tun; John A Copland
Journal:  Cancer Res       Date:  2014-06-24       Impact factor: 12.701

7.  Hyperpolarized 13C-pyruvate magnetic resonance reveals rapid lactate export in metastatic renal cell carcinomas.

Authors:  Kayvan R Keshari; Renuka Sriram; Bertram L Koelsch; Mark Van Criekinge; David M Wilson; John Kurhanewicz; Zhen J Wang
Journal:  Cancer Res       Date:  2012-11-30       Impact factor: 12.701

8.  Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes.

Authors:  S V Ivanov; I Kuzmin; M H Wei; S Pack; L Geil; B E Johnson; E J Stanbridge; M I Lerman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

9.  Therapeutic Targeting of SDHB-Mutated Pheochromocytoma/Paraganglioma with Pharmacologic Ascorbic Acid.

Authors:  Yang Liu; Ying Pang; Chunzhang Yang; Karel Pacak; Boqun Zhu; Ondrej Uher; Veronika Caisova; Thanh-Truc Huynh; David Taieb; Katerina Hadrava Vanova; Hans Kumar Ghayee; Jiri Neuzil; Mark Levine
Journal:  Clin Cancer Res       Date:  2020-03-09       Impact factor: 12.531

10.  Type III transforming growth factor-beta (TGF-beta) receptor mediates apoptosis in renal cell carcinoma independent of the canonical TGF-beta signaling pathway.

Authors:  Vitaly Margulis; Tapati Maity; Xiu-Ying Zhang; Simon J Cooper; John A Copland; Christopher G Wood
Journal:  Clin Cancer Res       Date:  2008-09-15       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.